Research Topics
Species | Robert D McBaneSummaryAffiliation: Mayo Clinic Country: USA Publications
| Collaborators
|
Detail Information
Publications
Fechtner syndrome: physiologic analysis of macrothrombocytopeniaR D McBane
Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
Blood Coagul Fibrinolysis 11:243-7. 2000..This case illustrates that 'giant' platelets are not universally present in Fechtner syndrome cases, although the platelets are enlarged. Finally, renal pathology other than Alport's nephropathy may be associated with this syndrome...
The impact of vitamin K-dependent factor depletion by warfarin on platelet-rich thrombosis after deep arterial injuryR D McBane
Division of Cardiovascular Medicine, Mayo Clinic and Foundation for Eduaction and Research, Rochester, Minnesota 55905, USA
J Thromb Haemost 2:1834-41. 2004..Arterial thrombosis correlates poorly with any single vitamin K-dependent factor but rather appears to be a function of the entire extrinsic coagulation pathway as measured by the PT-INR...
Importance of device evaluation for point-of-care prothrombin time international normalized ratio testing programsRobert D McBane
Department of Internal Medicine and Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
Mayo Clin Proc 80:181-6. 2005..To determine the accuracy of 2 commercially available point-of-care devices relative to plasma international normalized ratio (INR) values...
Images in vascular medicine. Cross-clamp injury: an unusual cause of intermittent claudicationRobert D McBane
Gonda Vascular Center, Mayo Clinic and Foundation for Education and Research, Rochester, MN 55905, USA
Vasc Med 11:173-4. 2006
Direct thrombin inhibitors are not equally effective in vivo against arterial thrombosis: in vivo evaluation of DuP714 and argatroban in a porcine angioplasty model and comparison to r-hirudinRobert D McBane
Division of Cardiovascular Medicine, Mayo Clinic and Foundation for Education and Research, Rochester, MN 55905, USA
Thromb Res 116:525-32. 2005..This affinity is inversely proportional to the inhibitory constant for the agent (Ki). Thrombin inhibitors, DuP714 (Ki=10(-11)) and argatroban (Ki=10(-8)), were compared to our previous studies with r-hirudin (Ki=10(-13))...
Atrial fibrillation and thrombosis: immunohistochemical differences between in situ and embolized thrombiW E Wysokinski
Division of Cardiovascular Medicine, Mayo Clinic and Foundation for Education and Research, Rochester, MN 55905, USA
J Thromb Haemost 2:1637-44. 2004..Quantitative immunohistochemistry was undertaken to define the composition of atrial thrombi and to explore morphological differences between atrial appendage thrombi and those that embolize...
Iliac venous stenting: antithrombotic efficacy of PD0348292, an oral direct Factor Xa inhibitor, compared with antiplatelet agents in pigsRobert D McBane
Section of Hematology Research, Mayo Clinic, 200 First Street, Rochester, MN 55905, USA
Arterioscler Thromb Vasc Biol 28:413-8. 2008..To address this issue, PD0348292, a direct Factor Xa inhibitor, was compared with antiplatelet therapy in a porcine venous stent model...
Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial)Robert D McBane
Division of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA
Am J Cardiol 105:17-24. 2010..Targeting the factors that led to the downregulation of PAI-1 in older patients with type 2 DM might offer an attractive strategy for reducing cardiovascular risk...
Periprocedural anticoagulation management of patients with venous thromboembolismRobert D McBane
Gonda Thrombophilia Clinic, Mayo Clinic, 200 First Street SW, Rochester, MN 55902, USA
Arterioscler Thromb Vasc Biol 30:442-8. 2010..The incidence of thromboembolism and bleeding related to periprocedural anticoagulation management of such patients is unknown...
Acquired and congenital risk factors associated with cerebral venous sinus thrombosisRobert D McBane
Division of Cardiovascular Medicine, Department of Biochemistry and Molecular Biology, Mayo Clinic and Foundation for Education and Research, Rochester, MN 55905, USA
Thromb Res 126:81-7. 2010....
The impact of peripheral arterial disease on circulating plateletsRobert D McBane
Section of Hematology Research, Mayo Clinic and Foundation for Education and Research, Rochester, MN 55905, USA
Thromb Res 113:137-45. 2004..To measure the effect of a defined arterial injury on platelet function, platelet samples were compared before and 30 min after elective angioplasty...
Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosisKrzysztof Karnicki
Division of Cardiovascular Medicine, Mayo Clinic, 200 First Street, Rochester, MN, 55905, USA
Thromb Haemost 99:759-66. 2008..In conclusion, PD0348292 inhibited arterial thrombosis comparable to aspirin plus clopidogrel. Perfusion chamber methodology may be useful in predicting in-vivo antithrombotic efficacy...
Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillationWaldemar E Wysokinski
Thrombophilia Clinic, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
Mayo Clin Proc 83:639-45. 2008....
Left atrial blood stasis and Von Willebrand factor-ADAMTS13 homeostasis in atrial fibrillationNaser Ammash
Department of Internal Medicine, Mayo Clinic and Foundation for Education and Research, Rochester, MN 55905, USA
Arterioscler Thromb Vasc Biol 31:2760-6. 2011..Von Willebrand factor (VWF) is associated with thromboembolism in AF. VWF thrombogenic activity is proportional to multimer size, which is regulated by VWF-cleaving protease (ADAMTS13)...
Peri-procedural anticoagulation management of mechanical prosthetic heart valve patientsPaul R Daniels
Mayo Clinic Thrombophilia Center, Gonda Vascular Center, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
Thromb Res 124:300-5. 2009....
Outcomes of venoplasty with stent placement for chronic thrombosis of the iliac and femoral veins: single-center experienceAndrew K Kurklinsky
Division of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
J Vasc Interv Radiol 23:1009-15. 2012..To assess retrospectively 30-day, 1-year, and 3-year patency of chronically occluded iliofemoral venous thrombotic lesions treated with stent placement in a case series from a single institution...
Correlation of point-of-care International Normalized Ratio to laboratory International Normalized Ratio in hemodialysis patients taking warfarinRobert W Hoel
Department of Pharmacy Services, Mayo Clinic, Rochester, MN 55905, USA
Clin J Am Soc Nephrol 4:99-104. 2009..Anemia is thought to reduce the accuracy of POC INR assay results. Whether POC INR testing could be implemented for hemodialysis patients on chronic warfarin, who are often anemic despite hematopoietic therapy, has not been established...
Factors contributing to individual propensity for arterial thrombosisKrzysztof Karnicki
Section of Hematology Research, Mayo Clinic and Foundation for Education and Research, Rochester, Minn 55905, USA
Arterioscler Thromb Vasc Biol 22:1495-9. 2002..CONCLUSIONS: Individual propensity for arterial thrombosis in pigs is more greatly influenced by blood components than by elements within the arterial wall...
Individual propensity for thrombosis: comparison of venous and arterial circulationsWaldemar Wysokinski
Section of Hematology Research Mayo Clinic, Rochester, MN 55905, USA
Thromb Res 122:390-6. 2008..We furthermore sought to determine whether the thrombotic propensity in the venous circulation is associated with similar propensity for arterial thrombosis...
Immunohistochemistry of thrombi following iliac venous stenting: a novel model of venous thrombosisBobby Burches
Section of Hematology Research Mayo Clinic, Rochester, Minnesota 55905, USA
Thromb Haemost 96:618-22. 2006..These may represent novel cellular targets for the prevention and treatment of venous thrombosis...
Prognostic value of ankle-brachial index and dobutamine stress echocardiography for cardiovascular morbidity and all-cause mortality in patients with peripheral arterial diseaseMallik R Thatipelli
Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
J Vasc Surg 46:62-70; discussion 70. 2007..To determine measures prognostic of adverse events, ankle-brachial index (ABI) was compared with dobutamine stress echocardiography (DSE) in patients referred to our vascular center for the evaluation of PAD...
Clinical characteristics and long-term follow-up of patients with renal vein thrombosisWaldemar E Wysokinski
Division of Cardiovascular Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA
Am J Kidney Dis 51:224-32. 2008..The rates of recurrent venous thrombosis and survival for patients with these 2 diseases were compared...
Accuracy of capillary whole blood international normalized ratio on the CoaguChek S, CoaguChek XS, and i-STAT 1 point-of-care analyzersBrad S Karon
Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Am J Clin Pathol 130:88-92. 2008..5 INR units from the reference method. Median bias between CoaguChek S capillary whole blood and laboratory plasma INRs changed over time, demonstrating the need for ongoing quality assurance measures for POC INR programs...
Survival and recurrence in patients with splanchnic vein thrombosesMallikarjun R Thatipelli
Division of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
Clin Gastroenterol Hepatol 8:200-5. 2010..It is therefore unclear whether thromboses of isolated segments represent unique entities. We compared etiologies, recurrence, and survival of patients with thromboses of different splanchnic venous segments...
Predicting left atrial thrombi in atrial fibrillationWaldemar E Wysokinski
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
Am Heart J 159:665-71. 2010..Nearly half of strokes in AF are due to noncardioembolic mechanisms for which antiplatelet therapy would be more appropriate. Previous attempts to develop such tools have been limited by including patients without proven cardioembolism...
Patients with a history of type II heparin-induced thrombocytopenia with thrombosis requiring cardiac surgery with cardiopulmonary bypass: a prospective observational case seriesGregory A Nuttall
Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota 55905, USA
Anesth Analg 96:344-50, table of contents. 2003..The patients receiving hirudin did well, but they had a large amount of bleeding, required transfusions of multiple allogeneic blood products, and had a frequent rate of reexploration of the mediastinum after CPB...
Clinical and echocardiographic measures governing thromboembolism destination in atrial fibrillationRobert D McBane
Division of Cardiovascular Medicine, Department of Health Sciences Research, Mayo Clinic and Foundation for Education and Research, 200 First Street S W, Rochester, MN 55905, USA
Thromb Haemost 99:951-5. 2008..Advanced age, atrial enlargement and other co-morbidities may increase the propensity for the formation of larger thrombi which may bypass the carotid orifice merely as a function of size...
Platelet factor XIII gene expression and embolic propensity in atrial fibrillationIzabella Gosk-Bierska
Mayo Clinic and Foundation for Education and Research, Rochester, Minnesota, USA
Thromb Haemost 106:75-82. 2011..Variable factor XIII gene expression in thrombi generated during NVAF may in part explain the propensity to embolisation...
Association of heparin-dependent antibodies and adverse outcomes in hemodialysis patients: a population-based studyLourdes Pena de la Vega
Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Mayo Clin Proc 80:995-1000. 2005..However, to our knowledge, this is the first study to show an association between elevated PF4-heparin antibodies and Increased mortality rates in hemodlalysis patients...
The association of active cancer with venous thromboembolism location: a population-based studyAlfonso J Tafur
Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA
Mayo Clin Proc 86:25-30. 2011..To test active cancer for an association with venous thromboembolism (VTE) location...
Three-month cumulative incidence of thromboembolism and bleeding after periprocedural anticoagulation management of arterial vascular bypass patientsHosam Attaya
Mayo Clinic Thrombophilia Center, Gonda Vascular Center, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
J Thromb Thrombolysis 35:100-6. 2013..This finding underscores the often tenuous nature of distal bypass grafts necessitating an aggressive approach to peri-procedural anticoagulation management...
Influence of anatomical location on arterial thrombosisKrzysztof Karnicki
Division of Cardiovascular Medicine, Mayo Clinic and Foundation for Education and Research, Rochester, MN 55905, USA
Arterioscler Thromb Vasc Biol 22:342-7. 2002..Regional differences in arterial hemodynamics may account for substantial differences in thrombosis arising from deep arterial injury...
Fibrin d-dimer concentration, deep vein thrombosis symptom duration, and venous thrombus volumeAndrew K Kurklinsky
Division of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55905, USA
Angiology 62:253-6. 2011..To determine the relationship between fibrin D-dimer levels, symptom duration, and thrombus volume, consecutive patients with incident deep venous thrombosis (DVT) were evaluated...
Reduced high shear platelet adhesion to the vascular media: defective von Willebrand factor binding to the interstitial collagenErzsebet Komorowic
Section of Hematology Research, Mayo Clinic and Foundation for Education and Research, Rochester, MN 55905, USA
Thromb Haemost 87:763-70. 2002..Our data suggest that the media, despite its fibrillar collagen content, evidenced by electron microscopy, is defective for vWf-binding, which may explain its thromboresistant nature at high shear rates...
Ovarian vein thrombosis: incidence of recurrent venous thromboembolism and survivalEwa M Wysokinska
Division of Cardiovascular Medicine, Mayo Clinic and Foundation for Education and Research, Rochester, Minnesota, 55905 USA
Thromb Haemost 96:126-31. 2006..Therefore general treatment guidelines for lower extremity DVT may be applicable. Poor survival rates in OVT are principally governed by the presence of malignancy...
Inhibition and reversal of platelet-rich arterial thrombus in vivo: direct vs. indirect factor Xa inhibitionK Karnicki
Division of Cardiology, May Clinic, Rochester, MN 55905, USA
J Thromb Haemost 2:2162-9. 2004..2, effectively inhibits thrombosis and promptly deaggregates thrombi induced by arterial injury. In contrast, indirect FXa inhibition with enoxaparin was ineffective...
The effects of irreversible JPEG compression on an automated algorithm for measuring carotid artery intima-media thickness from ultrasound imagesN J Hangiandreou
Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA
J Digit Imaging 15:258-60. 2002..This initial study indicates that compression at 10:1 using baseline JPEG should have little effect on IMT measurements made using the current algorithm, and that compression to 20:1 or 30:1 may be feasible...
Images in vascular medicine. Fibromuscular dysplasia: an atypical cause of intermittent claudicationWaldemar E Wysokinski
Division of Cardiovascular Medicine, Mayo Clinic and Foundation for Education and Research, Rochester, MN, USA
Vasc Med 9:315-7. 2004
Physical and enzymatic perturbation of the architecture of the Tunica media destroys its inherent thromboresistanceErzsebet Komorowicz
Department of Medical Biochemsitry, Semmelweis University, Budapest, Hungary
Thromb Haemost 88:827-33. 2002..Collagen in the media may be complexed with another vessel wall component shielding the vWf-binding sites. Mechanical or biochemical processes unmask these sites, and increase the thrombogenicity of the vessel wall...
Brain lesions in cerebral venous sinus thrombosisAlexander Y Zubkov
Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
Stroke 40:1509-11. 2009..Analyze the relationship between the location and extent of sinus thrombosis and presence and severity of brain lesions...
Efficacy and safety of intravenous phytonadione (vitamin K1) in patients on long-term oral anticoagulant therapyR C Shields
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
Mayo Clin Proc 76:260-6. 2001..In small doses, it does not prolong the patient's time to return to therapeutic anticoagulation...
Dabigatran: a primer for neurosurgeonsJennifer E Fugate
Division of Critical Care Neurology, Mayo Clinic, Rochester, Minnesota, USA
World Neurosurg 79:154-8. 2013..This study sought to present an overview of dabigatran, a new anticoagulant, and to discuss the implications for the perioperative management of patients taking dabigatran...
Early subclinical coronary artery calcification in young adults who were pediatric kidney transplant recipientsMichael B Ishitani
William J von Liebig Transplant Center, Mayo Medical School, Foundation and Clinic, Rochester, MN, USA
Am J Transplant 5:1689-93. 2005..These data suggest young adults who received pediatric kidney transplants are at increased risk for developing early CAC and need close monitoring to detect early CAD so as to prevent premature cardiac morbidity and mortality...
Platelet characteristics associated with coronary artery diseaseR D McBane
Division of Cardiovascular Medicine, Section of Hematology Research, Mayo Clinic and Foundation for Education and Research, 200 S.W. First Street, Rochester, MN 55905, USA
J Thromb Haemost 1:1296-303. 2003..The genesis of these platelet characteristics is not fully explained by focal acute arterial injury and may reflect exposure to systemic atherosclerosis or the atherogenic process...
Cerebral venous sinus thrombosis: Incidence of venous thrombosis recurrence and survivalI Gosk-Bierska
Division of Cardiovascular Medicine, Mayo Clinic, 200 S.W. First St, Rochester, MN 55905, USA
Neurology 67:814-9. 2006..Compared with DVT, survival rates are higher following CVST but are adversely influenced by malignancy and older age...
Acute venous disease: venous thrombosis and venous traumaMark H Meissner
Department of Surgery, University of Washington School of Medicine, Seattle 98195, USA
J Vasc Surg 46:25S-53S. 2007..Venous injuries are similarly under-reported and the true incidence is unknown. Current recommendations include repair of injuries to the major proximal veins. If repair not safe or possible, ligation should be performed...
Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practiceEmoke Posan
Visiting Scientist from University of Debrecen, Faculty of Medicine, 2nd. Department of Medicine, Debrecen, Hungary
Thromb Haemost 90:483-90. 2003..When clinical suspicion is strong, testing should be supplemented with assays of von Willebrand factor and platelet aggregometry...
Cardiomyopathy associated with celiac diseaseNisheeth K Goel
Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
Mayo Clin Proc 80:674-6. 2005..However, with early diagnosis and treatment with a gluten-free diet, cardiomyopathy in patients with celiac disease may be completely reversible...
Surgical pathology of nonbacterial thrombotic endocarditis in 30 patients, 1985-2000P W Eiken
Mayo Medical School, Division of Anatomic Pathology, Mayo Clinic, Rochester, Minn. 55905, USA
Mayo Clin Proc 76:1204-12. 2001....
